By combining multi-omic analyses with in vitro characterization of KEAP1 loss in thyroid cancer, we demonstrate that these mutations are functionally relevant and capable of promoting tumorigenesis across diverse genetic landscapes. The gene discussed is KEAP1; the disease is thyroid cancer.